Tectonic Therapeutic, Inc.
TECX
$17.08
$1.7211.20%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -2.19% | 8.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 22.05% | 30.78% | |||
| Operating Income | -22.05% | -30.78% | |||
| Income Before Tax | -19.50% | -28.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -25.64% | -28.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -25.64% | -28.55% | |||
| EBIT | -22.05% | -30.78% | |||
| EBITDA | -22.60% | -33.04% | |||
| EPS Basic | -15.40% | -10.83% | |||
| Normalized Basic EPS | -9.77% | -10.83% | |||
| EPS Diluted | -15.40% | -10.83% | |||
| Normalized Diluted EPS | -9.77% | -10.83% | |||
| Average Basic Shares Outstanding | 8.87% | 15.99% | |||
| Average Diluted Shares Outstanding | 8.87% | 15.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||